These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1382245)
1. Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat. Mason GS; Elliott PJ Neuropharmacology; 1992 Aug; 31(8):757-60. PubMed ID: 1382245 [TBL] [Abstract][Full Text] [Related]
2. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444 [TBL] [Abstract][Full Text] [Related]
3. Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Hagan RM; Ireland SJ; Jordan CC; Beresford IJ; Deal MJ; Ward P Neuropeptides; 1991 Jun; 19(2):127-35. PubMed ID: 1719445 [TBL] [Abstract][Full Text] [Related]
4. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions. Paris JM; Mitsushio H; Lorens SA Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417 [TBL] [Abstract][Full Text] [Related]
5. Intra-midbrain raphe injections of the neurokinin-3 agonist senktide inhibit food and water intake in the rat. Paris JM; Mitsushio H; Lorens SA Pharmacol Biochem Behav; 1991 Jan; 38(1):223-6. PubMed ID: 1708148 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Couture R; Laneuville O; Guimond C; Drapeau G; Regoli D Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):547-57. PubMed ID: 2482449 [TBL] [Abstract][Full Text] [Related]
7. Further studies on the effects of selective neurokinin agonists upon the activation of micturition reflex in rats. Evidence for a dual NK-1 receptor mediated excitatory and inhibitory activity. Palea S; Dalforno G; Gaviraghi G; Hagan RM; Trist DG; Pietra C Neuropeptides; 1993 May; 24(5):285-91. PubMed ID: 7687043 [TBL] [Abstract][Full Text] [Related]
8. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Overton P; Elliott PJ; Hagan RM; Clark D Eur J Pharmacol; 1992 Mar; 213(1):165-6. PubMed ID: 1379929 [TBL] [Abstract][Full Text] [Related]
9. The motor actions of natural neurokinins and their specific agonists on the gastrointestinal tract of the rat. Chang FY; Lee SD; Yeh GH; Wang PS Chin J Physiol; 1992; 35(4):337-48. PubMed ID: 1285005 [TBL] [Abstract][Full Text] [Related]
10. Tachykinin NK(3)receptor involvement in anxiety. Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489 [TBL] [Abstract][Full Text] [Related]
11. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583 [TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1, -2 and -3 receptors are candidates for a role in the opiate withdrawal response in guinea-pigs. Johnston PA; Chahl LA Regul Pept; 1993 Jul; 46(1-2):376-8. PubMed ID: 7692541 [No Abstract] [Full Text] [Related]
13. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Juszczak M; Boczek-Leszczyk E J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097 [TBL] [Abstract][Full Text] [Related]
14. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Liu R; Ding Y; Aghajanian GK Neuropsychopharmacology; 2002 Sep; 27(3):329-40. PubMed ID: 12225691 [TBL] [Abstract][Full Text] [Related]
15. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. Jacques L; Couture R; Drapeau G; Regoli D Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):170-9. PubMed ID: 2478892 [TBL] [Abstract][Full Text] [Related]
16. Neurokinin receptors in the rabbit iris sphincter characterised by novel agonist ligands. Hall JM; Mitchell D; Morton IK Eur J Pharmacol; 1991 Jun; 199(1):9-14. PubMed ID: 1716575 [TBL] [Abstract][Full Text] [Related]
17. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors? Tauer U; Zhao Y; Hunt SP; Culman J Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977 [TBL] [Abstract][Full Text] [Related]
18. Selective neurokinin NK1 and NK2 receptor agonists infused in the substantia nigra of the rat increase vacuous chewing. Liminga U Eur J Pharmacol; 1993 Apr; 235(2-3):177-81. PubMed ID: 7685289 [TBL] [Abstract][Full Text] [Related]
19. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity. Paris JM; Lorens SA J Pharmacol Exp Ther; 1989 Oct; 251(1):388-93. PubMed ID: 2795467 [TBL] [Abstract][Full Text] [Related]
20. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]